Echo Street Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Echo Street Capital Management’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-862	Closed	-$309K	–	62
2023 Q3	$309K	Buy	+862	New	+$333K	﹤0.01%	368
2023 Q2	–	Sell	-1,131	Closed	-$542K	–	465
2023 Q1	$542K	Buy	+1,131	New	+$529K	﹤0.01%	246
2022 Q4	–	Sell	-1,024	Closed	-$427K	–	501
2022 Q3	$427K	Sell	1,024 -258	-20%	-$129K	﹤0.01%	314
2022 Q2	$635K	Sell	1,282 -324	-20%	-$169K	0.01%	255
2022 Q1	$905K	Buy	1,606 +730	+83%	+$440K	0.01%	259
2021 Q4	$662K	Sell	876 -322	-27%	-$241K	﹤0.01%	348
2021 Q3	$894K	Buy	1,198 +215	+22%	+$161K	0.01%	271
2021 Q2	$633K	Buy	983 +496	+102%	+$302K	﹤0.01%	296
2021 Q1	$278K	Buy	+487	New	+$288K	﹤0.01%	435
2020 Q3	–	Sell	-2,792	Closed	-$1.26M	–	143
2020 Q2	$1.26M	Buy	+2,792	New	+$1.23M	0.01%	232

Other funds holding BIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Echo Street Capital Management's BIO Position: Q4 2023 in Review

Echo Street Capital Management sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2023, closing a stake of 862 shares — an estimated $309K sold.

Echo Street Capital Management first reported a position in BIO in Q2 2020 and held it in 10 quarters. The position peaked at $1.26M in Q2 2020. 484 funds tracked by Wall St. Rank hold BIO as of Q4 2023.

Echo Street Capital Management reported no remaining Bio-Rad Laboratories Class A position as of Q4 2023 after selling out during the quarter.
Echo Street Capital Management sold 862 Bio-Rad Laboratories Class A shares in Q4 2023, an estimated $309K.
Echo Street Capital Management first reported a position in Bio-Rad Laboratories Class A in Q2 2020 and held it in 10 quarters.
Echo Street Capital Management's Bio-Rad Laboratories Class A position peaked at $1.26M in Q2 2020.
484 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2023.

Based on Echo Street Capital Management's 13F filing for Q4 2023, filed 8 Feb 2024.